Clinical, Radiological and Genetic Investigation of Fahr's Disease - Marins Ferreira, Cristiane;P. Alvarenga, Regina;Antão Paiva, Carmen Lucia
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Fahr's disease (FD) or Familial Primary Calcification of the Basal Nuclei is a rare neurodegenerative disease, with an incidence of less than 1 in 1 million inhabitants (SALEEM et al., 2013) worldwide, autosomal dominant, characterised by symmetrical and bilateral calcifications in the basal nuclei (nb) and other areas of the cerebral cortex, thus allowing for diverse clinical presentations, mainly with extrapyramidal and psychiatric symptoms. In recent years, mutations in four genes have been identified as causing the disease (SLC20A2, PDGFRB, PDGFB and XPR1) allowing for a specific…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Fahr's disease (FD) or Familial Primary Calcification of the Basal Nuclei is a rare neurodegenerative disease, with an incidence of less than 1 in 1 million inhabitants (SALEEM et al., 2013) worldwide, autosomal dominant, characterised by symmetrical and bilateral calcifications in the basal nuclei (nb) and other areas of the cerebral cortex, thus allowing for diverse clinical presentations, mainly with extrapyramidal and psychiatric symptoms. In recent years, mutations in four genes have been identified as causing the disease (SLC20A2, PDGFRB, PDGFB and XPR1) allowing for a specific genotype-phenotype correlation as shown in Table 1 (TADIC et al., 2015). The author of this research is a neurologist working in the field of neuropediatrics. Through clinical history and examinations, she identified the likelihood of FD in the proband and found ways to develop this work in postgraduate studies.
Autorenporträt
Cristiane Marins Ferreira es Neuróloga en el Hospital Alcides Carneiro. Áreas de especialidad: Neurología, Neuropediatría, Neurofisiología Clínica. Es miembro fundador de la Asociación de Neurología del Estado de Río de Janeiro, miembro efectivo de la Sociedad Brasileña de Neurofisiología Clínica y de la Liga Brasileña de Epilepsia.